Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Earnings

Q1 2022		Est.		Actual		Surprise
EPS		(EXPECTED)2022-02-07
REV		(EXPECTED)2022-02-07

Q4 2021		Est.		Actual		Surprise
EPS		-1.220		-1.220		0.0000
REV		26.340M		23.575M		-2.765M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Enanta Pharmaceuticals Questions & Anwsers

Q: What sector and industry does Enanta Pharmaceuticals (ENTA) operate in?

Enanta Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

How do I buy Enanta Pharmaceuticals (ENTA) stock?

You can purchase shares of Enanta Pharmaceuticals (NASDAQ: ENTA) through any online brokerage.

View our list of the best stock brokerages.

Who are Enanta Pharmaceuticals's (ENTA) competitors?

Other companies in Enanta Pharmaceuticals’s space includes: Xencor (NASDAQ:XNCR), Agios Pharmaceuticals (NASDAQ:AGIO), Ironwood Pharmaceuticals (NASDAQ:IRWD), Bicycle Therapeutics (NASDAQ:BCYC) and Alector (NASDAQ:ALEC).

What is the target price for Enanta Pharmaceuticals (ENTA) stock?

The latest price target for Enanta Pharmaceuticals (NASDAQ: ENTA) was reported by Oppenheimer on November 24, 2021. The analyst firm set a price target for 73.00 expecting ENTA to fall to within 12 months (a possible -16.64% downside). 15 analyst firms have reported ratings in the last year.

Current Stock Price for Enanta Pharmaceuticals (ENTA)?

The stock price for Enanta Pharmaceuticals (NASDAQ: ENTA) is $87.57 last updated Mon Nov 29 2021 21:00:04 GMT+0000 (Coordinated Universal Time).

Does Enanta Pharmaceuticals (ENTA) pay a dividend?

There are no upcoming dividends for Enanta Pharmaceuticals.

When is Enanta Pharmaceuticals (NASDAQ:ENTA) reporting earnings?

Enanta Pharmaceuticals’s $Q1 earnings are confirmed for after-market on February 7, 2022.

Is Enanta Pharmaceuticals (ENTA) going to split?

There is no upcoming split for Enanta Pharmaceuticals.

What sector and industry does Enanta Pharmaceuticals (ENTA) operate in?

Enanta Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD